Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
11 2019
Historique:
received: 19 04 2019
revised: 07 08 2019
accepted: 12 08 2019
pubmed: 2 11 2019
medline: 22 9 2020
entrez: 2 11 2019
Statut: ppublish

Résumé

Intrathecal inflammation, compartmentalized in cerebrospinal fluid (CSF) and in meningeal infiltrates, has fundamental role in inflammation, demyelination, and neuronal injury in cerebral cortex in multiple sclerosis (MS). Since the exact link between intrathecal inflammation and mechanisms of cortical pathology remains unknown, we aimed to investigate a detailed proteomic CSF profiling which is able to reflect cortical damage in early MS. We combined new proteomic method, TRIDENT, CSF analysis, and advanced 3T magnetic resonance imaging (MRI), in 64 MS patients at the time of diagnosis and 26 controls with other neurological disorders. MS patients were stratified according to cortical lesion (CL) load. We identified 227 proteins differently expressed between the patients with high and low CL load. These were mainly related to complement and coagulation cascade as well as to iron homeostasis pathway (30 and 6% of all identified proteins, respectively). Accordingly, in the CSF of MS patients with high CL load at diagnosis, significantly higher levels of sCD163 (P < 0.0001), free hemoglobin (Hb) (P < 0.05), haptoglobin (P < 0.0001), and fibrinogen (P < 0.01) were detected. By contrast, CSF levels of sCD14 were significantly (P < 0.05) higher in MS patients with low CL load. Furthermore, CSF levels of sCD163 positively correlated (P < 0.01) with CSF levels of neurofilament, fibrinogen, and B cell-related molecules, such as CXCL13, CXCL12, IL10, and BAFF. Intrathecal dysregulation of iron homeostasis and coagulation pathway as well as B-cell and monocyte activity are strictly correlated with cortical damage at early disease stages.

Identifiants

pubmed: 31675181
doi: 10.1002/acn3.50893
pmc: PMC6856609
doi:

Substances chimiques

Blood Coagulation Factors 0
Complement System Proteins 9007-36-7
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2150-2163

Subventions

Organisme : Italian Ministry of Health
ID : GR-2013-02-355322
Pays : International
Organisme : Italian MS Foundation grant
ID : FISM 16/17/F14
Pays : International

Informations de copyright

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Brain. 2018 Jul 1;141(7):2066-2082
pubmed: 29873694
Brain. 2018 Jun 1;141(6):1637-1649
pubmed: 29688408
Nat Immunol. 2018 Nov;19(11):1212-1223
pubmed: 30323343
J Neuroimmunol. 2006 Dec;181(1-2):145-9
pubmed: 17046070
Brain Behav. 2016 Jul 11;6(9):e00509
pubmed: 27688939
J Neuroimmunol. 2000 Apr 3;104(1):58-67
pubmed: 10683515
Nat Commun. 2015 Sep 10;6:8164
pubmed: 26353940
Biochim Biophys Acta. 2015 Jan;1852(1):92-103
pubmed: 25463632
Brain Pathol. 2007 Jan;17(1):38-44
pubmed: 17493036
Neurology. 2009 Dec 1;73(22):1914-22
pubmed: 19949037
J Neuroimmunol. 2012 May 15;246(1-2):85-95
pubmed: 22458983
Neurology. 2015 Jul 7;85(1):12-3
pubmed: 25888561
Blood. 2002 Jan 1;99(1):378-80
pubmed: 11756196
Brain. 1999 Jan;122 ( Pt 1):17-26
pubmed: 10050891
Ann Neurol. 2010 Oct;68(4):477-93
pubmed: 20976767
Mult Scler. 2017 Mar;23(3):473-482
pubmed: 27260699
EMBO Rep. 2012 Sep;13(9):798-810
pubmed: 22868664
PLoS One. 2013;8(3):e57104
pubmed: 23533572
Nat Rev Neurosci. 2015 Mar;16(3):147-58
pubmed: 25697158
Ann Neurol. 2017 Aug;82(2):259-270
pubmed: 28719020
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Semin Thromb Hemost. 2013 Nov;39(8):876-80
pubmed: 24108468
Immunity. 1994 Sep;1(6):509-16
pubmed: 7534618
Neurosci Lett. 2014 Oct 17;582:130-2
pubmed: 24942652
Am J Pathol. 2011 Mar;178(3):1316-28
pubmed: 21356382
J Biol Chem. 2014 Jan 10;289(2):778-88
pubmed: 24275664
J Neuroimmunol. 2011 Aug 15;237(1-2):73-9
pubmed: 21737148
Brain. 2011 Sep;134(Pt 9):2755-71
pubmed: 21840891
J Neuroimmunol. 2007 Jul;187(1-2):179-86
pubmed: 17537523
J Neuroinflammation. 2017 Feb 21;14(1):40
pubmed: 28222766
Ann Neurol. 2013 Dec;74(6):848-61
pubmed: 23868451
Wellcome Open Res. 2016 Nov 15;1:10
pubmed: 27996064
Ann Neurol. 2018 Apr;83(4):739-755
pubmed: 29518260
Front Immunol. 2015 Dec 24;6:636
pubmed: 26732544
Acta Neuropathol. 2015 Dec;130(6):765-81
pubmed: 26511623
PLoS One. 2015 Apr 10;10(4):e0119681
pubmed: 25860354
Neuron. 2017 Dec 6;96(5):1003-1012.e7
pubmed: 29103804
Nat Rev Neurosci. 2018 May;19(5):283-301
pubmed: 29618808
J Neurol Sci. 2009 Jul 15;282(1-2):5-11
pubmed: 19201002
Ann Neurol. 2014 Feb;75(2):303-8
pubmed: 24740641
PLoS One. 2014 Mar 17;9(3):e92331
pubmed: 24637679
J Neuroimmunol. 2017 Aug 15;309:88-99
pubmed: 28601295
Brain. 2014 Aug;137(Pt 8):2271-86
pubmed: 24893707
Brain Res. 2014 Jul 7;1571:25-38
pubmed: 24814387
Blood. 2009 Jul 23;114(4):764-71
pubmed: 19380867
Nature. 2001 Jan 11;409(6817):198-201
pubmed: 11196644

Auteurs

Roberta Magliozzi (R)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom.

Simon Hametner (S)

Neuroimmunology Department, Center for Brain Research, Medical University of Vienna, Wien, Austria.

Francesco Facchiano (F)

Department of Oncology and Molecular Oncology, Istituto Superiore di Sanità, Rome, Italy.

Damiano Marastoni (D)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Stefania Rossi (S)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Department of Oncology and Molecular Oncology, Istituto Superiore di Sanità, Rome, Italy.

Marco Castellaro (M)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Alberto Poli (A)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Federico Lattanzi (F)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Andrea Visconti (A)

Medical Affairs Department, Merck Serono, Rome, Italy.

Richard Nicholas (R)

Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom.

Richard Reynolds (R)

Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom.

Salvatore Monaco (S)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Hans Lassmann (H)

Neuroimmunology Department, Center for Brain Research, Medical University of Vienna, Wien, Austria.

Massimiliano Calabrese (M)

Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH